Skip to main content
logo
Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.85
+0.74 (10.41%)
At close: Aug 14, 2026, 4:00 PM EDT
7.58
-0.27 (-3.44%)
After-hours: Aug 14, 2026, 7:48 PM EDT

Aspire Biopharma Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
0.10.01---
Revenue Growth
-----
Cost of Revenue
0.120.01---
Gross Profit
-0.02-0---
Selling, General & Admin
-7.94.31.070.290.42
Research & Development
0.840.920.140.070.18
Operating Expenses
-7.075.221.210.360.6
Operating Income
7.04-5.22-1.21-0.36-0.6
Interest Expense
-9.31-8.53-0.1--
Other Non Operating Income (Expenses)
4.43.77---
EBT Excluding Unusual Items
2.2-9.99-1.31-0.36-0.6
Merger & Restructuring Charges
-14.36-14.13---
Other Unusual Items
1.12-0.36---
Pretax Income
-11.05-24.48-1.31-0.36-0.6
Income Tax Expense
--000
Net Income
-11.05-24.48-1.31-0.36-0.6
Net Income to Common
-11.05-24.48-1.31-0.36-0.6
Net Income Growth
-----
Shares Outstanding (Basic)
000443-
Shares Outstanding (Diluted)
000443-
Shares Change
1015.92%116.69%-100.00%--
EPS (Basic)
-33.33-491.27-56.96-0.00-
EPS (Diluted)
-33.34-491.27-56.96-0.00-
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
-25.04%-1.87%---
Operating Margin
7210.15%-84167.06%---
Profit Margin
-11314.13%-394725.06%---
EBIT
7.04-5.22-1.21-0.36-0.6
SEC Filings: 10-K · 10-Q